...
首页> 外文期刊>NeuroImage: Clinical >Hippocampal subfield volumetry in mild cognitive impairment, Alzheimer's disease and semantic dementia
【24h】

Hippocampal subfield volumetry in mild cognitive impairment, Alzheimer's disease and semantic dementia

机译:轻度认知障碍,阿尔茨海默氏病和语义性痴呆症的海马亚场量测

获取原文
           

摘要

Background Hippocampal atrophy is a well-known feature of Alzheimer's disease (AD), but sensitivity and specificity of hippocampal volumetry are limited. Neuropathological studies have shown that hippocampal subfields are differentially vulnerable to AD; hippocampal subfield volumetry may thus prove to be more accurate than global hippocampal volumetry to detect AD. Methods CA1, subiculum and other subfields were manually delineated from 40 healthy controls, 18 AD, 17 amnestic Mild Cognitive Impairment (aMCI), and 8 semantic dementia (SD) patients using a previously developed high resolution MRI procedure. Non-parametric group comparisons and receiver operating characteristic (ROC) analyses were conducted. Complementary analyses were conducted to evaluate differences of hemispheric asymmetry and anterior-predominance between AD and SD patients and to distinguish aMCI patients with or without β-amyloid deposition as assessed by Florbetapir-TEP. Results Global hippocampi were atrophied in all three patient groups and volume decreases were maximal in the CA1 subfield (22% loss in aMCI, 27% in both AD and SD; all p<0.001). In aMCI, CA1 volumetry was more accurate than global hippocampal measurement to distinguish patients from controls (areas under the ROC curve=0.88 and 0.76, respectively; p=0.05) and preliminary analyses suggest that it was independent from the presence of β-amyloid deposition. In patients with SD, whereas the degree of CA1 and subiculum atrophy was similar to that found in AD patients, hemispheric and anterior–posterior asymmetry were significantly more marked than in AD with greater involvement of the left and anterior hippocampal subfields. Conclusions The findings suggest that CA1 measurement is more sensitive than global hippocampal volumetry to detect structural changes at the pre-dementia stage, although the predominance of CA1 atrophy does not appear to be specific to AD pathophysiological processes. Highlights ? Using 3T MRI, hippocampal subfields were measured in aMCI, AD and SD and controls. ? CA1 atrophy was found to be predominant in all patient groups. ? CA1 volume was the best discriminating measure between controls and aMCI patients. ? AD and SD differed in asymmetry and anterior-predominance, not in subfield atrophy.
机译:背景海马萎缩是阿尔茨海默氏病(AD)的一个众所周知的特征,但是海马容积的敏感性和特异性受到限制。神经病理学研究表明,海马亚区有不同程度的易感性。因此,海马亚场容量测定可能比全球海马容量测定更准确地检测AD。方法使用先前开发的高分辨率MRI程序,从40位健康对照,18位AD,17位记忆轻度认知障碍(aMCI)和8位语义性痴呆(SD)患者中手动划定CA1,亚下丘及其他子区域。进行了非参数组比较和接收器工作特性(ROC)分析。进行了补充分析,以评估AD和SD患者之间的半球不对称性和前占优势,并通过Florbetapir-TEP评估来区分有或没有β-淀粉样蛋白沉积的aMCI患者。结果在所有三个患者组中,整体海马体均萎缩,CA1子区的体积减少最大(aMCI减少22%,AD和SD均减少27%;所有p <0.001)。在aMCI中,CA1量测比全海马测量更能准确区分患者和对照组(ROC曲线下的面积分别为0.88和0.76; p = 0.05),初步分析表明它与β淀粉样蛋白沉积无关。在SD患者中,CA1和下丘脑萎缩的程度与AD患者相似,但在半球和前后不对称性方面,AD的显着性要比AD患者高得多,左,前海马亚区的累及程度更大。结论研究结果表明,CA1的测量比痴呆前期的海马体积测量更灵敏,尽管CA1萎缩的优势似乎并不特定于AD病理生理过程。强调 ?使用3T MRI,在aMCI,AD和SD以及对照组中测量海马亚区。 ?发现CA1萎缩在所有患者组中都是主要的。 ? CA1量是对照组和aMCI患者之间最好的区分指标。 ? AD和SD在不对称性和前占优势方面有所不同,在亚视野萎缩方面没有差异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号